Specifically, the α3β-integrin-tetraspanin protein complex has been linked to an invasive phenotype of the MDA-MB-231 breast cancer cell line, via the activation of MMP-2 and signaling pathways controlling the cytoskeleton [36]. Here, MMP2 is linked to breast carcinoma.